Introduction: Chronic diseases are major causes of death and disability and often require multiple prescribed medications for treatment and control. Public health emergencies (e.g., disasters due to natural hazards) that disrupt the availability or supply of these medications may exacerbate chronic disease or even cause death. Problem: A repository of chronic disease pharmaceuticals and medical supplies organized for rapid response in the event of a public health emergency is desirable. However, there is no science base for determining the contents of such a repository. This study provides the first step in an evidence-based approach to inform the planning, periodic review, and revision of repositories of chronic disease medications. Methods: Data from the 2004 National Hospital Ambulatory Medical Care Survey (NHAMCS) were used to examine the prescription medication needs of persons presenting to US hospital emergency departments for chronic disease exacerbations. It was assumed that the typical distribution of cases for an emergency department will reflect the patient population treated in the days after a public health emergency. The estimated numbers of prescribed drugs for chronic conditions that represent the five leading causes of death, the five leading primary diagnoses for physician office visits, and the five leading causes of disease burden assessed by disability-adjusted life years are presented.
Repositories for Chronic Diseases medications) and medical supplies (e.g., oxygen, intravenous infusion supplies, airway maintenance supplies) organized for rapid response in the event of a public health emergency may be beneficial in order to provide services to displaced populations and restore affected healthcare systems after the event. 9 While assets from the federally managed [US] Strategic National Stockpile may be sent to the site of a national crisis, the initial response will be managed locally. Planning at each level involves complex decisionmaking concerning the formulation of a repository of pharmaceuticals and medical supplies. Insufficient medication supplies may lead to inadequate treatment, whereas excessive supplies represent wasted resources. 10 In addition, it may be beneficial for such a repository to be subject to a periodic science-or evidence-based review, as opposed to one based largely on the consensus of an expert committee.
To address this need and inform the consideration of medications and supplies for chronic conditions, the prescription medication needs of persons admitted to emergency departments for chronic disease exacerbations were examined. The underlying assumption is that the typical distribution of cases for an emergency department will reflect the patient population treated in the days (>24 hours) after the onset of a public health emergency (i.e., disaster due to natural hazard), plus a potential increase in the number of patients who have sustained minor traumatic injuries (e.g., injuries and wounds) related to recovery efforts and an increase in medication refills. 11 Data from the National Hospital Ambulatory Medical Care Survey the United States, chronic diseases account for about 70% of all deaths, and an estimated 133 million Americans live with one or more forms of chronic disease. 3 Additionally, more than 80% of Medicare beneficiaries aged ≥65 years have at least one chronic condition, 65% have two or more chronic conditions, 43% have three or more chronic conditions, and 24% have four or more chronic conditions. 4 Most of these chronic diseases require one or more prescribed medications. This high prevalence and the associated use of multiple medications that control chronic diseases have increased concerns about the potential health consequences of public health emergencies, particularly disasters due to natural hazards, that may disrupt the availability or supply of essential medications and medical supplies for chronic disease prevention and control. 5, 6 For instance, during or following an event, pharmacies in or around an affected area may close or quickly deplete their inventories, making it difficult for patients who remain in the area to obtain critical medications (new prescriptions or refills) and medical supplies. 7 Displaced persons who evacuate without essential medications and medical supplies, or those who deplete their prescriptions before being able to return home, also are vulnerable to acute exacerbations of their condition(s). 8 Acute exacerbation of chronic diseases can lead to severe complications or death, and was a leading concern among medical personnel treating displaced persons after Hurricane Katrina in 2005. 6 A repository of pharmaceuticals (e.g., vasodilators, diuretics, thrombolytics, analgesics, antibiotics, life-support (NHAMCS) were used to examine the types of medications prescribed to patients who were treated in emergency departments. Given the prevalence of chronic disease in the United States and previous problems with medication availability during and after disasters, 12-14 the approach of this study focused on medications used by persons with chronic conditions identified as among the five leading causes of death, five leading causes of disability, and five leading indications for outpatient physician office visits.
This approach adequately captures the underlying clinical vulnerability of the population with prevalent chronic disease.
Methods
The NHAMCS is a national, probability sample survey conducted by the National Center for Data collected from each sample visit included information on the medications provided during the visit. Generic names and standard therapeutic drug classification codes used in the National Drug Code Directory were available for up to eight medications in 2004. Records with drug mentions were isolated in order to process the drug data. Estimates of drug mentions were obtained by multiplying the patient visit weight by the number of medications recorded at the sample visit.
The estimated number of drug mentions by several conditions that define the chronic disease burden in the US are listed in the Appendix. 1, 16, 17 Visit records were categorized according to the physician's primary (first listed) discharge diagnosis for the visit, coded according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). All analyses were completed using SAS v9 (Cary, NC) and SUDAAN v9 (Research Triangle Park, NC).
Results
In 2004, an estimated 110.2 million visits were made to hospital emergency departments in the US, or about 38.2 visits per 100 persons. The estimated numbers of emergency department visits made for conditions that define the chronic disease burden (Figure 1 ) in the US are in Figure 2 . An estimated 2.3 million visits were for heart disease, the leading cause of death in the US. Nearly 3.4 million visits were made to an emergency department by patients with chronic lung disease, and of these, 55% were asthma related. Mental disorders (3.8 million) and arthropathies (3.1 million) also accounted for a large number of emergency department visits during 2004.
The 20 most frequent drug mentions by drug class for all emergency department visits during 2004 are in Table 1 . Overall, the five drug classes mentioned most frequently were narcotic analgesics (30.7 million), non-steroidal antiinflammatory drugs (25.2 million), non-narcotic analgesics (15.2 million), sedatives and hypnotics (10.4 million), and cephalosporins (8.2 million).
The 10 most frequent drug mentions for selected chronic conditions are summarized in Table 2 . The estimated number of drug mentions is listed by drug class and the most frequently mentioned generic drug within each class. For example, an estimated 707,000 mentions of diuretics occurred during 2004 for emergency visits of patients with a principal diagnosis of heart disease. The diuretic identified most frequently was furosemide (632,000 drug mentions). Similarly, there were 3.2 million mentions of anti-asthmatics/bronchodilators during emergency department visits for chronic obstructive pulmonary disease, and the agent mentioned most frequently was albuterol sulfate (1.65 million drug mentions). Table 3 is a summary of drug categories mentioned during emergency department visits for leading causes of chronic disease burden in the US in 2004. Analgesics and controlled substances, metabolic and nutrient agents, and psychotropic agents were among the leading drugs mentioned for each of the leading causes of the chronic disease burden defined in Figure 1 . Gastrointestinal agents or anti-emetics, antibacterial/antifungal/antiviral agents, diuretics, beta-blockers, and anti-asthmatics/bronchodilators/inhaled corticosteroids also were common across the leading chronic conditions.
Discussion
Disasters due to natural hazards and other public health emergencies are capable of overwhelming the resources of an affected community, and in particular, the capacity of the healthcare system. The immediate health burden on a community, often measured in terms of morbidity and mortality, losses or disruptions in infrastructure and supplies, and damage to the health infrastructure, varies with the nature of the event. 18 In areas in which community resources are drained by emergency responses or are insufficient to meet the health needs of the population, the provision of additional resources often are necessary to provide services for displaced populations and restore the affected healthcare systems.
The underlying medical vulnerability of a population should be an important factor in determining the composition of a pharmaceutical and medical supply repository. Authorities may closely approximate this medical vulnerability by considering the leading causes of death, leading causes of disability, and most frequent indications for physician visits. Knowledge of the underlying medical vulnerability of a population also will be useful for authorities, since the nature of the event (e.g., earthquake, volcanic eruption, heat wave, hurricane) likely will influence which patients may be more impacted (e.g., patients with respiratory, cardiovascular, gastrointestinal, or dermatological conditions).
The 25 most frequently mentioned drug categories prescribed for the prevention and control of chronic diseases during ambulatory care visits to emergency departments in non-federal, short-stay, or general hospitals in the US in 2004 were identified. Within these categories, the drugs most frequently prescribed for more than one major leading cause of death or disability included medications for mental health, analgesics, metabolic and nutrient-related agents, gastrointestinal agents, diuretics, beta-blockers, bronchodilators and other anti-asthmatic medications, angiotensin-converting enzyme inhibitors, neurologic agents, calcium channel blockers, hormonal agents, antihistamines, hypoglycemic agents, antianginal agents, and anticoagulants. Thus, this analysis suggests which drug categories might be considered, as well as the relative quantities of each, depending on the number of diseases for which they frequently are prescribed. the number of medications needed if large numbers of individuals are separated from their core medications, such as during a flood. Certain populations, such as the elderly, are more likely to have multiple co-morbid chronic conditions. This analysis utilized the primary discharge diagnosis; therefore, the number of medications for chronic condiThe results should be interpreted with consideration of the following limitations. The findings reflect the prescription medication needs of persons admitted to emergency departments for chronic disease exacerbations, as well as medications, such as thrombolytics and heparin, administered for acute conditions. As such, they may underestimate 20 In a study of medication needs of displaced Hurricane Katrina survivors residing at a San Antonio evacuee center over a 20-day period, nearly three-quarters of defined daily doses of medication dispensed by local retail pharmacies to these survivors were for chronic care medicines including medications for the management of respiratory conditions (e.g., inhaled steroids, inhaled anti-cholinergics), cardiovascular agents (e.g., anti-hypertensives, anti-arrhythmics, anti-hyperlipidemics), neuropsychotropic agents (e.g., anti-depressants, anti-psychotics), and medications for management of endocrine disorders (e.g., insulin, oral hypoglycemics, thyroid replacements). 21 The findings in this analysis provide one evidence-based approach for informing public health preparedness in terms of planning for and review of the prescription medication needs of clinically vulnerable populations with prevalent chronic disease.
Conclusions
Chronic diseases are a major cause of morbidity and mortality, and most chronic diseases require multiple prescribed medications for treatment and control. The underlying clinical vulnerability for chronic disease is adequately captured by the five leading causes of death, five leading causes of disability, and five leading indications for outpatient physician office visits. This analysis provides a first step in an evidence-based approach for planning for the prevention and control of chronic diseases during public health emergencies.
tions may be underestimated. Also, it is important to reinforce that these estimates are most helpful for addressing the short-term needs of displaced populations and do not address issues of continuity of care that are so important for the long-term management of many chronic diseases. Future research may consider incorporating information from community pharmacies to better reflect long-term medication needs in a given community. In addition, it is important that the evidence-based approach for periodic review presented here is updated regularly with the most recent data to reflect changes in pharmaceutical management of disease and in the burden of chronic diseases in the geographic area of interest. Traditionally, disaster planning efforts regarding pharmaceutical and medical supply repositories have reflected an emphasis on emergency relief for injuries and chemical, biological, radiological, nuclear and explosive events. 5 Although medications to address these types of events are critically important, they may not be sufficient in the setting of a large-scale disaster that leads to large numbers of displaced persons and interruptions in the supplies of routine medications. Persons with chronic diseases such as heart disease, cancer, stroke, chronic respiratory diseases, and diabetes, and those with chronic disability, also will have urgent needs for ongoing care and medical support. 5 Chronic conditions and medications for the treatment and management of chronic diseases were common reasons for visits to emergency-treatment facilities (e.g., hospitals, disaster medical assistance teams, military-aid stations) during the period immediately following Hurricane Katrina in
